The final frontier – crossing the blood‐brain barrier
William S. Sly, Carole Vogler
doaj +1 more source
Blood-Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems. [PDF]
He Y +10 more
europepmc +1 more source
Transcytotic transportation of size-controlled nanocarriers into dystrophic skeletal muscle leads to therapeutic outcome in mice. [PDF]
Liu X +16 more
europepmc +1 more source
Tingting Song,1 Wenyu Wang,1 Yan Wu,2 Chaolong Liu,1 Lu Yuan,1 Zhihong Sun,1 Jingjing Zhang,1 Yong Sun1 1Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, Shandong, 266071, People’s Republic of China; 2Department of Obstetrics
Song T +7 more
doaj
Lipid raft proteomics identify endothelial myosin-9 (MYH9) as a regulator of low-density lipoprotein transcytosis and atherosclerosis. [PDF]
Jang E +12 more
europepmc +1 more source
Crossing the barrier: targeting epithelial receptors for antigen delivery to the mucosal immune system [PDF]
Cox, Eric +3 more
core +1 more source
Intravenous rAAV9 Produces Time-Resolved Parenchymal Labeling Downstream of the Vasculature in Adult Mice. [PDF]
Soto-Avellaneda A +7 more
europepmc +1 more source
From Gut to Systemic Circulation: Molecular Strategies of Botulinum Neurotoxin Complexes. [PDF]
Mondy J, Lemichez E.
europepmc +1 more source
From oversight to insight: the curious case of the endothelial insulin receptor. [PDF]
Rajala R.
europepmc +1 more source
MFSD2A: a molecular nexus linking blood-brain barrier, lipid metabolism, and ischemia-reperfusion injury. [PDF]
Li C, Ibrahim MM, Fang C.
europepmc +1 more source

